生产企业：Harbour BioMed, Windward Bio
HBM9378 (also known as SKB378/WIN378) is a novel fully human, ultra-long-acting anti-TSLP monoclonal antibody being evaluated in the global Phase 2/3 POLARIS-1 study in asthma and the Phase 2 SIRIUS study in COPD.
HBM9378 (also known as SKB378/WIN378) is a novel fully human, ultra-long-acting anti-TSLP monoclonal antibody being evaluated in the global Phase 2/3 POLARIS-1 study in asthma and the Phase 2 SIRIUS study in COPD.
Fully human monoclonal antibody targeting thymic stromal lymphopoietin (TSLP); potently inhibits the TSLP ligand.
共 2 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
